MedTrace Logo

The Effect of Dexamethasone on Sugammadex Reversal

NCT02137395 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2015-08-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether dexamethasone extends the duration of recovery from anesthesia.

Conditions

  • Incomplete Reversal of Neuromuscular Block

Interventions

DRUG

Dexamethasone

dexamethasone administration, intravenously

DRUG

Placebo

saline administration intravenously

Sponsors & Collaborators

  • Cukurova University

    lead OTHER

Principal Investigators

  • Ersel Gulec, M.D. · Cukurova University Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137395 on ClinicalTrials.gov